4.2 Review

Transfusion-Related Acute Lung Injury During Liver Transplantation: A Scoping Review

Journal

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Volume 36, Issue 8, Pages 2606-2615

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.jvca.2021.04.033

Keywords

liver transplantation; transfusion-related acute lung injury; massive transfusion; acute respiratory distress syndrome; transfusion reaction

Ask authors/readers for more resources

This scoping review summarizes the existing literature on transfusion-related acute lung injury (TRALI) during the perioperative period of liver transplantation. The review found that the incidence of TRALI after liver transplant was 0.68%, and a significant proportion of patients diagnosed with TRALI died during the postoperative period.
Liver transplantation is associated with significant blood loss, often requiring massive blood product transfusion. Transfusion-related acute lung injury (TRALI) is a devastating cause of transfusion-related deaths. While reports have investigated the general incidence of TRALI, the incidence of TRALI specifically following transfusion during liver transplant remains unclear. This scoping review summarizes existing literature regarding TRALI during the liver transplantation perioperative period. Databases were searched for all articles and abstracts reporting on TRALI after liver transplantation. Data collected included number of patients studied, patient characteristics, incidences of TRALI, TRALI characteristics, and patient outcomes. The primary outcome investigated was the incidence of TRALI in the setting of liver transplantation. Thirteen fulltext citations were included in this review. The incidence of TRALI post-liver transplant was 0.68% (65 of 9,554). Based on reported transfusion data, patients diagnosed with TRALI received an average of 10.92 +/- 10.81 units of packed red blood cells (pRBC), 20.05 +/- 15.72 units of fresh frozen plasma, and 5.75 +/- 10.00 units of platelets. Common interventions following TRALI diagnosis included mechanical ventilation with positive end-expiratory pressure, inhaled high-flow oxygen, inhaled pulmonary vasodilator, and pharmacologic treatment using pressors or inotropes, corticosteroids, or diuretics. Based on reported mortality data, 26.67% of patients (12 of 45) diagnosed with TRALI died during the postoperative period. This scoping review underscores the importance of better understanding the incidence and presentation of TRALI after liver transplant surgery. The clinical implications of these results warrant the development of identification and management strategies for liver transplant patients at increased risk for developing TRALI. (C) 2021 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available